SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Nanotherapeutic Delivers Synergy, Boosting Immunotherapy/Chemotherapy Without Toxicity
Nanotechnology has the potential to make immunotherapy/chemotherapy combinations dramatically effective, even against aggressive tumors.
September 26, 2021
 · 
4 min read
 · 
Gail Dutton
Iovance Chief Medical Officer Dr. Friedrich Graf F
Drug Development
Evidence Mounting for TILs as Possible First-Line Cancer Therapy
Study: Adoptive cell transfer of tumor-infiltrating lymphocytes (ACT-TILs) is more effective in patients who have not been treated with checkpoint inhibitors than in those who have undergone one or more therapies.
September 23, 2021
 · 
4 min read
 · 
Gail Dutton
Business
Aurion Biotech CEO: “How You React Now Determines Your Next Success”
Aurion Biotech is focused on curative and restorative treatments for corneal endothelial disease.
September 22, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
National Survey: “Trust” at the Heart of Low U.S. Vaccination Rates
The survey of 20,699 Americans found that the unvaccinated – 35% of respondents – didn’t trust that the vaccines were safe or effective.
September 22, 2021
 · 
5 min read
 · 
Gail Dutton
Business
Fountain’s William Greene is Striving to Extend Human Health Span
Last spring he joined Fountain Therapeutics as CEO, a company that merges artificial intelligence (AI) with machine learning (ML) to develop therapeutics for degenerative diseases.
September 7, 2021
 · 
5 min read
 · 
Gail Dutton
Business
Adyn Test Brings Precision Medicine to Birth Control Prescription Choices
This is an effort to eliminate severe adverse reactions by matching the birth control to the genetics and hormones of the individual.
August 31, 2021
 · 
4 min read
 · 
Gail Dutton
Renovacor CMO Dr. Marc Semigran/Courtesy of Renova
Business
Renovacor’s Marc Semigran Transitioned to Industry to Put Patients First
The burgeoning genetic capabilities were instrumental in causing Semigran to transition into the biotech industry.
August 30, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
How COVID-19 is Still Changing the Biopharma Industry, Now and in the Future
The development of COVID-19 vaccines, which took only months from the initial gene sequencing to the time shots were in arms, was the biggest story of 2020 alongside the pandemic itself.
August 25, 2021
 · 
4 min read
 · 
Gail Dutton
Business
Shoreline Launches into “Era of Cell Therapy” with $4 Billion in Partnerships
Shoreline Biosciences was propelled into the proverbial catbird’s seat this summer with two mega-deals, and now plans to double its employee base from 50 to 100 in the coming months.
August 24, 2021
 · 
4 min read
 · 
Gail Dutton
Biotech Beach
Oral Remdesivir Could Lower COVID Hospitalizations, Preclinical Study Says
An oral version of remdesivir is being developed by scientists at the University of California San Diego to combat the SARS-CoV-2 virus early in its infection cycle.
August 23, 2021
 · 
3 min read
 · 
Gail Dutton
Drug Development
E-Protein Channel Blockers May Lead the Next Fight Against COVID-19
Research emerging from Israel identified eight already-approved compounds that inhibit the activity of the E-protein channels in the virus’s membrane.
August 20, 2021
 · 
4 min read
 · 
Gail Dutton
Biotech Company Earns Two Patents for Targeted Delivery of Psychedelic Meds
Psycheceutical Inc. was issued two patents by the United States Patent and Trademark Office for what it calls a “precision duplicity” approach to delivering psychedelic drugs to patients.
August 19, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
mRNA Looks Beyond COVID-19 Vaccines to Therapeutics and Diagnostics
mRNA has built its reputation as a type of vaccine to fight COVID-19, but its capabilities extend beyond vaccines into therapeutics and even diagnostics.
August 17, 2021
 · 
4 min read
 · 
Gail Dutton
Wyss Institute at Harvard University
Genetown
Diagnostic Face Mask Detects SARS-CoV-2 Quickly, with PCR-Like Accuracy
The prototype offers PCR-like precision without a power-source, and is stable at room temperature for many months.
August 17, 2021
 · 
4 min read
 · 
Gail Dutton
Policy
Will China’s Anti-Capitalist Hardline Take on Biopharma? Not Likely, Experts Say
In the past few weeks, China reminded the world that it is, first and foremost, a Communist nation. The recent crackdowns on the high-tech and education industries make some wonder what other changes will be next.
August 17, 2021
 · 
4 min read
 · 
Gail Dutton
Load More